Moreover, the varied mechanisms driving the cell surface translocation of GRP78 in tumor cells offer great opportunities to develop therapeutic strategies against csGRP78.[16] All these characteristics render GRP78 an exceptionally appealing target antigen for tumor therapies. The gene discussed is HSPA5; the disease is neoplasm.